Medgenics: Biotech Showcase Conference (Medgenics) - Feb 2, 2015 - Anticipated initiation of P2 trial in peritoneal dialysis in Q1 2015; Anticipated initiation of P2 trial in myelodysplastic syndrome in H1 2015; Anticipated initiation of P2 trial in beta thalassemia intermedia in H2 2015; Anticipated initiation of P2 trial in hypo-responders to ESA in H1 2015
Anticipated new P2 trial • Biosimilar
|